Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome

ConclusionInitiation of eculizumab within 7 days of hospitalisation is associated with lower dialysis rates, less time in ICU, less plasmapheresis, and lower hospitalisation costs compared with late initiation.

http://link.springer.com/10.1007/s40273-019-00862-w

Source: PharmacoEconomics - December 11, 2019 Category: Health Management Source Type: research